Conditional BDNF delivery from astrocytes rescues memory deficits, spine density and synaptic properties in the 5xFAD mouse model of Alzheimer disease by Pins, Benoit de et al.
Development/Plasticity/Repair
Conditional BDNF Delivery from Astrocytes Rescues
Memory Deficits, Spine Density, and Synaptic Properties in
the 5xFAD Mouse Model of Alzheimer Disease
X Benoit de Pins,1,2,3 X Carmen Cifuentes-Díaz,1,2,3 Amel Thamila Farah,1,2,3 Laura López-Molina,4,5,6
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Engineering, Paris 75005, France, 3Institut du Fer à Moulin, Paris F-75005, France, 4Departament de Biomedicina, Facultat de Medicina, Institut de
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It has been well documented that neurotrophins, including brain-derived neurotrophic factor (BDNF), are severely affected in Alzhei-
mer’s disease (AD), but their administration faces a myriad of technical challenges. Here we took advantage of the early astrogliosis
observed in an amyloid mouse model of AD (5xFAD) and used it as an internal sensor to administer BDNF conditionally and locally. We
first demonstrate the relevance of BDNF release from astrocytes by evaluating the effects of coculturing WT neurons and BDNF-deficient
astrocytes. Next, we crossed 5xFAD mice with pGFAP:BDNF mice (only males were used) to create 5xFAD mice that overexpress BDNF
when and where astrogliosis is initiated (5xF:pGB mice). We evaluated the behavioral phenotype of these mice. We first found that BDNF
from astrocytes is crucial for dendrite outgrowth and spine number in cultured WT neurons. Double-mutant 5xF:pGB mice displayed
improvements in cognitive tasks compared with 5xFAD littermates. In these mice, there was a rescue of BDNF/TrkB downstream
signaling activity associated with an improvement of dendritic spine density and morphology. Clusters of synaptic markers, PSD-95 and
synaptophysin, were also recovered in 5xF:pGB compared with 5xFAD mice as well as the number of presynaptic vesicles at excitatory
synapses. Additionally, experimentally evoked LTP in vivo was increased in 5xF:pGB mice. The beneficial effects of conditional BDNF
production and local delivery at the location of active neuropathology highlight the potential to use endogenous biomarkers with early
onset, such as astrogliosis, as regulators of neurotrophic therapy in AD.
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Introduction
Alzheimer disease (AD) is the most common form of dementia in
the aging population, accounting for 60%– 80% of the cases. The
disease is a progressive neurodegenerative disorder characterized
by the presence of extracellular amyloid plaques composed of
amyloid- (A) surrounded by dystrophic neurites and neurofi-
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Significance Statement
Recent evidence places astrocytes as pivotal players during synaptic plasticity and memory processes. In the present work, we first
provide evidence that astrocytes are essential for neuronal morphology via BDNF release. We then crossed transgenic mice
(5xFAD mice) with the transgenic pGFAP-BDNF mice, which express BDNF under the GFAP promoter. The resultant double-
mutant mice 5xF:pGB mice displayed a full rescue of hippocampal BDNF loss and related signaling compared with 5xFAD mice
and a significant and specific improvement in all the evaluated cognitive tasks. These improvements did not correlate with
amelioration of  amyloid load or hippocampal adult neurogenesis rate but were accompanied by a dramatic recovery of struc-
tural and functional synaptic plasticity.
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brillary tangles (NFTs) (Alzheimer’s Association, 2012). Further
pathological hallmarks of the disease include inflammatory pro-
cesses, synaptic and neuronal loss, cerebral atrophy, and cerebral
amyloid angiopathy (Wirths and Bayer, 2012). The complex pro-
gression of neurodegeneration in AD patients results in memory
impairment and decline in other cognitive abilities often com-
bined with noncognitive symptoms, such as mood and personal-
ity changes (Alzheimer’s Association, 2012).
One of the most promising therapies in AD is the use of neu-
rotrophic factors, such as NGF or BDNF (Allen and Dawbarn,
2006). Indeed, BDNF plays important roles in neural survival and
synaptic plasticity (Lynch et al., 2008). In line with this, BDNF is
reduced early in the course of the disease in transgenic mouse
models of AD (Kaminari et al., 2017), and TrkB deletion acceler-
ates and worsens the phenotype of these mice (Devi and Ohno,
2015), whereas TrkB agonists improve it (Devi and Ohno, 2012;
Zhang et al., 2014). Alterations in the BDNF-TrkB system could
account for memory deficits, neuronal cell death, and synaptic
plasticity alterations observed in AD (von Bohlen Und Halbach
and von Bohlen Und Halbach, 2018). BDNF-TrkB-associated
downstream molecular pathways include PLC, ERK, and Akt
signaling. Interestingly, dysregulation of these pathways is able to
modulate the levels of essential synaptic proteins, such as post-
synaptic density-95 (PSD-95) and synaptophysin (Tartaglia et al.,
2001; Robinet and Pellerin, 2011; Parsons et al., 2014; Yoshii and
Constantine-Paton, 2014; Zhang et al., 2017), which in turn are
altered in AD models (Yuki et al., 2014; Dorostkar et al., 2015).
Finally, altered BDNF-TrkB pathway could also result in deficient
adult neurogenesis in the hippocampus (Waterhouse et al.,
2012), which could in turn contribute to the memory loss in AD
(Toda and Gage, 2018).
Several strategies have been proposed to produce/deliver
BDNF to counteract neurodegeneration. However, all of them
are associated with deleterious secondary effects or are not satis-
factory enough (Lindvall et al., 2004). Important drawbacks are
the risk of tumorigenesis, insufficient cell survival in cell therapy,
or invasiveness of some delivery systems, as well as the lack of
control on the production and delivery of the neurotrophin be-
cause too high levels can be neurotoxic (Martínez-Serrano and
Björklund, 1996; Rubio et al., 1999; Pineda et al., 2007; Kells et al.,
2008). Furthermore, these strategies do not target specifically the
diseased tissue or deliver appropriate levels of the neurotrophin
depending on the severity of the symptoms.
Astrocytes in AD are reactive at early stages, have impaired
Ca 2 signaling, regulate -amyloid burden, and influence syn-
aptic plasticity alterations also contributing to excitotoxicity
(Acosta et al., 2017). Interestingly, astrocytes normally express
the BDNF protein, although at lesser levels than neurons (Saha et
al., 2006; Giralt et al., 2010; Fulmer et al., 2014; Hong et al., 2016).
Therefore, engineered astrocytes could be good candidates to
release neurotrophic factors. Indeed, genetically modified astro-
cytes have been used with positive results in some models of
neurodegeneration (Yoshimoto et al., 1995; Carpenter et al.,
1997). This strategy could be relevant for AD as the numbers of
reactive astrocytes increases gradually as the disease progress
(Song et al., 2015). Moreover, astrogliosis has been shown to be
one of the specific hallmarks of disease progression in mouse
models of AD (Oakley et al., 2006). Because of this increase in
astrocytes, and the fact that astrogliosis leads to increased GFAP
promoter activation, one would predict that the use of this pro-
moter as a self-regulator would provide neurotrophic support at
the time when it is critically needed. Therefore, here we sought to
investigate the role of BDNF from astrocytes in normal neuronal
dendritic growth and whether this could be exploited to design
advanced and conditional therapies in AD models.
Materials and Methods
Astrocyte/neuron cocultures. Primary astrocyte cultures were obtained
from P1 to P3 BDNF / and BDNF / mouse pups (Ernfors et al.,
1994) (IMSR catalog #EM:00247, RRID:IMSR_EM:00247) by hip-
pocampal dissections. Extracted tissue was dissociated and placed in 25
cm 2 flasks in a MEM 1 conditioned media NM-15 (20% FBS; Invitro-
gen; D-glucose 90 mM) with L-glutamine and Earle’s salts (Invitrogen)
and placed in an incubator at 37°C with 5% CO2. A tail biopsy was
obtained from each pup for genotyping. After two passages, cultures were
purified by agitating in a shaker during 10 min at 400 rpm. Medium with
undesired floating cells was replaced, and flasks were placed in an incu-
bator for 2 h at 37°C. Next, flasks were agitated again for 16 –18 h at 250
rpm. Finally, medium with floating cells was replaced with new medium.
Once astrocytes reached confluence, they were seeded in 24-well plaques
and allowed to reach confluence. Then, 1 d before the addition of hip-
pocampal neurons, astrocyte cultures were preincubated with neuro-
basal medium (Invitrogen) containing 1 ml per 50 ml of B27 supplement
(Invitrogen) and 50 ml of GlutaMAX (100; Invitrogen). Hippocampal
neurons were prepared from E17 C57BL/6J mouse embryos (pregnant
mice from Charles River). The neuronal cell suspension was low density
seeded in the 24-well plaques already containing astrocytes (10,000 cells
cm 2). Cocultures were fixed at 6 DIV or 20 DIV after neuron seeding to
evaluate the number of dendrites and dendritic spines, respectively. Cul-
tures collected at 20 DIV were transfected 48 h before cell fixation with
Transfectine (Bio-Rad) following the manufacturer’s instructions. Cells
were transfected with a previously described construct expressing GFP
(Giralt et al., 2017) to allow dendritic spine density counting in isolated
hippocampal neurons.
qPCR assay. Total RNA from astrocyte cultures (see above) and
HEK293 cells was extracted using the RNeasy Lipid Tissue Mini Kit
(QIAGEN). Total RNA (500 ng) was used to synthesize cDNA using
random primers with the High Capacity cDNA Reverse Transcription
Kit (Applied Biosystems). The cDNA synthesis was performed at 37°C
for 120 min in a final volume of 20 l according to the manufacturer’s
instructions. The cDNA was then analyzed by qPCR using the following
gene expression assays: 18S (NR_003286; Integrated DNA Technologies)
and BDNF (NM_001048139; Integrated DNA Technologies). RT-PCR
was performed in 12 l of final volume on 96-well plates using the Pre-
mix Ex Taq (Probe qPCR; Takara Biotechnology). Reactions included
the following: Segment 1, 1 cycle of 30 s at 95°C; Segment 2, 40 cycles of
5 s at 95°C and 20 s at 60°C. All RT-PCR assays were performed in
duplicate and repeated for at least three independent experiments. To
provide negative controls and exclude contamination by genomic DNA,
the RT was omitted in the cDNA synthesis step, and the samples were
subjected to the PCR in the same manner with each TaqMan Gene Ex-
pression Assay. The RT-PCR data were analyzed using the MxProTM
qPCR analysis software version 3.0 (Stratagene). Quantification was per-
formed with the Comparative Quantitation Analysis program of this
software and using the 18S gene expression as internal loading control.
Immunocytochemistry and neuronal morphology assessment. Fixed cells
were permeabilized in Triton X-100 0.5% (v/v) for 10 min, and then
blocking was performed with 10 g/L BSA in PBS for 1 h. Cells were
incubated with a mouse monoclonal antibody for MAP2 (1:800, Sigma-
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Martín for help in animal handling and care during in vivo experiments.
The authors declare no competing financial interests.
Correspondence should be addressed to Albert Giralt at albertgiralt@ub.edu.
https://doi.org/10.1523/JNEUROSCI.2121-18.2019
Copyright © 2019 the authors 0270-6474/19/392442-18$15.00/0
2442 • J. Neurosci., March 27, 2019 • 39(13):2441–2458 de Pins et al. • BDNF Conditional Delivery from Astrocytes in AD
Aldrich catalog #M1406, RRID:AB_477171) at 4°C overnight. After three
washes with PBS, cells were incubated with the corresponding Cy3-
coupled fluorescent secondary antibody (1:200; Jackson ImmunoRe-
search Laboratories catalog #715-165-150, RRID:AB_2340813). After
washing twice with PBS, the coverslips were mounted with Vectashield
(Vector Laboratories). Hippocampal neuron staining was observed with
a confocal SP5-II (see below).
Mouse lines. For this study, we used the transgenic mouse line 5xFAD
(MMRRC catalog #034840-JAX, RRID:MMRRC_034840-JAX). 5xFAD
mice overexpress the 695-amino acid isoform of the human amyloid
precursor protein (APP695) carrying the Swedish, London, and Florida
mutations under the control of the murine Thy-1 promoter. In addition,
they express human presenilin-1 (PSEN-1) carrying the M146L/L286V
mutation, also under the control of the murine Thy-1 promoter (Oakley
et al., 2006). We crossed 5xFAD mice with the previously generated
pGFAP-BDNF mice (Giralt et al., 2010) to obtain 5xFAD mice that over-
express BDNF under the GFAP promoter (5xF:pGB mice). For astrocyte
cultures, we used P1-P3 BDNF / and BDNF / mice (Ernfors et al.,
1994) (IMSR catalog #EM:00247, RRID:IMSR_EM:00247). Mouse
genotyping for pGFAP-BDNF, 5xFAD, and BDNF / mice was per-
formed from a tail biopsy, as previously described (Oakley et al., 2006;
Giralt et al., 2009, 2010) by Charles River services. The animals were
housed with access to food and water ad libitum in a colony room kept at
19°C–22°C and 40%– 60% humidity, under a 12:12 h light/dark cycle.
Experimental animals were all males and used at 8 months of age and in
accordance with the ethical guidelines (Declaration of Helsinki and NIH
Publication no. 85-23, revised 1985, European Community Guidelines,
and French Agriculture and Forestry Ministry guidelines for handling
animals, decree 87849, license A 75-05-22) and approved by the local
ethical committee.
Western blot. Mice were deeply anesthetized in a CO2 chamber, the
brains quickly removed, hippocampus dissected out, frozen in dry ice,
and stored at 80°C until use. Briefly, tissue was sonicated in 250 ml of
lysis buffer (PBS, 1% Nonidet P40 [v/v], 1 g/L SDS, 5 g/L sodium deoxy-
cholate, protease inhibitors mixture 1:1000 [Sigma-Aldrich], and 2 g/L
sodium orthovanadate) and centrifuged at 12,000 rpm for 20 min, and
the pellet was discarded. Proteins (15 mg) from hippocampal or cortical
tissue were analyzed by SDS-PAGE (7.5% acrylamide, w/v) and trans-
ferred to nitrocellulose membranes (Millipore). Membranes were
blocked in TBS-T (150 mM NaCl, 20 mM Tris-HCl, pH 7.5, 0.05% [v/v]
Tween 20) with 50 g/L nonfat dry milk and 50 g/L BSA. Immunoblots
were probed with anti-GFAP (1:1000, Agilent Technologies catalog
#Z0334, RRID:AB_10013382), anti-BDNF (1:1000, Santa Cruz Biotech-
nology catalog #sc-546, RRID:AB_630940), anti-Akt (1:1000, Cell Sig-
naling Technology catalog #9272, RRID:AB_329827), anti-ERK (1:1000,
Cell Signaling Technology catalog #4695, RRID:AB_390779), anti-PLC
(1:1000, Cell Signaling Technology catalog #2822, RRID:AB_2163702),
anti-phosphor-Akt (1:1000, Cell Signaling Technology catalog #4056,
RRID:AB_331163), anti-phosphor-ERK (1:1000, Cell Signaling Tech-
nology catalog #9101, RRID:AB_331646), anti-phosphor-PLC (1:1000,
Cell Signaling Technology catalog #2821, RRID:AB_330855), or anti--
tubulin (1:10,000, Sigma-Aldrich catalog #T9026, RRID:AB_477593).
All blots were incubated overnight at 4°C with shaking, in the pres-
ence of the primary antibody in PBS with 0.2 g/L sodium azide. After
several washes in TBS-T, blots were incubated with anti-rabbit IgG
IRdye800CW-coupled or anti-mouse IgG IRdye700DX-coupled an-
tibodies (1/2000, Rockland Immunochemicals) and signal detected
by the Odyssey system (Li-Cor) and analyzed using ImageJ.
Golgi staining, spine counting, and morphological analysis. Fresh brain
hemispheres were processed following the Golgi-Cox method as de-
scribed previously (Giralt et al., 2017). Essentially, mouse brain hemi-
spheres were incubated in the dark for 21 d in filtered dye solution (10 g
L 1 K2Cr2O7, 10 g L
1 HgCl2, and 8 g L
1 K2CrO4). The tissue was then
washed 3  2 min in water and 30 min in 90% ethanol (EtOH) (v/v); 200
m sections were cut in 70% EtOH on a vibratome (Leica Microsystems)
and washed in water for 5 min. Next, they were reduced in 16% (v/v)
ammonia solution for 1 h before washing in water for 2 min and fixation
in 10 g l 1 Na2S2O3 for 7 min. After a 2 min final wash in water, sections
were mounted on superfrost coverslips, dehydrated for 3 min in 50%,
then 70%, 80%, and 100% EtOH, incubated for 2  5 min in a 2:1
isopropanol:EtOH mixture, followed by 1  5 min in pure isopropanol
and 2  5 min in xylol. Bright-field images of Golgi-impregnated stra-
tum radiatum dendrites from hippocampal CA1 pyramidal neurons
were captured with a Nikon DXM 1200F digital camera attached to a
Nikon Eclipse E600 light microscope (100 oil objective). Only fully
impregnated pyramidal neurons with their soma found entirely within
the thickness of the section were used. Image z stacks were taken every 0.2
mm and at 1024  1024 pixel resolution, yielding an image with pixel
dimensions of 49.25  49.25 mm. Z stacks were deconvolved using the
Huygens software (Scientific Volume Imaging) to improve voxel resolu-
tion and to reduce optical aberration along the z axis. The total number of
spines counting and their morphology categorization were performed by
using the NeuronStudio freeware (NeuronStudio, RRID:SCR_013798).
At least 60 dendrites per group from at least 5 mice per genotype were
counted. For spine morphology analysis, we analyzed between 2000 and
3000 spines (500 spines per mouse from 5 mice per group). Each spine
was categorized as having or not having a neck. Spines were defined as
stubby if they did not contain a visible neck. Spines with necks were
separated into thin and mushroom spines based on head width. Filopo-
dia, defined as protrusions 1.5 m in length without a head, were ex-
cluded from the analysis of spine subtypes. Spines with heads less than
the average width were categorized as thin, and those with heads greater
than the average width were categorized as mushroom as previously
described (Giralt et al., 2017). From these measures, the percentage of the
various spine types was obtained. Picture acquisition and subsequent
analysis were performed independently by two investigators blind to
genotypes and results were then pooled. Overall differences between the
results were minor.
Tissue fixation and immunofluorescence. Animals were deeply anesthe-
tized with pentobarbital (60 mg/kg) and intracardially perfused with a
4% (w/v) PFA solution in 0.12 M sodium phosphate, pH 7.2. Brains were
removed and postfixed overnight in the same solution, cryoprotected
with 300 g/L sucrose in 20 mM sodium phosphate, pH 7.5, 150 mM NaCl
(PBS) with 0.2 g/L sodium azide, and frozen in dry ice-cooled isopentane.
Serial coronal sections (30 m) obtained with a cryostat were processed
for immunohistochemistry as free-floating sections. They were
washed three times in PBS, permeabilized 15 min by shaking at room
temperature with PBS containing (v/v) 0.3% Triton X-100 and 3% nor-
mal goat serum (Pierce Biotechnology). After three washes, brain sec-
tions were incubated overnight by shaking at 4°C with antibodies for
anti-PSD-95 (1:500, Millipore catalog #MAB1596, RRID:AB_2092365),
anti-synaptophysin (1:500, Synaptic Systems catalog #101 011, RRID:
AB_887824), or anti-phosphor-TrkB Y816 (1:350, Abcam catalog
#ab75173, RRID:AB_1281172) in PBS with 0.2 g/L sodium azide. After
incubation with primary antibody, sections were washed three times and
then placed 2 h on a shaking incubator at room temperature with the
subtype-specific fluorescent secondary AlexaFluor-488 anti-rabbit (1:
250, Thermo Fisher Scientific catalog #A32731, RRID:AB_2633280) or
anti-mouse 555 (1:250, Thermo Fisher Scientific catalog #A32727, RRID:
AB_2633276). No signal was detected in control sections incubated in the
absence of the primary antibody.
Confocal imaging and analysis. Dorsal hippocampus in fixed tissue and
fixed primary cultures were imaged using a Leica Microsystems Confocal
SP5-II at the Institut du Fer à Moulin Cell and Tissue Imaging facility,
with a 40 or 63 numerical aperture lens with 5 digital zoom and
standard (1 Airy disc) pinhole (1 AU) and frame averaging (3 frames per
z step) were held constant throughout the study. Confocal z stacks were
taken every 0.2 m for in vitro experiments and every 2 m for in vivo
experiments, and at 1024  1024 pixel resolution. The in vitro Sholl
analysis, the dendritic spine counting, the in vivo analysis of PSD95- and
synaptophysin-positive clusters, and the colocalization of double-labeled
PSD-95/phospho-TrkB Y816-positive clusters were analyzed with the
freeware ImageJ (ImageJ, RRID:SCR_003070). Briefly, for in vivo imag-
ing analysis, for each mouse, at least 3 slices of 30 m containing dorsal
hippocampal tissue were analyzed. Up to 3 representative images, from
CA1-stratum radiatum layer, were obtained from each slice. For the in
vitro analysis, in the Sholl experiment, we evaluated 45– 60 neurons, all of
them MAP2-positive from 3 different cultures. To estimate the density of
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dendritic spines, 31– 41 dendrites from MAP2-positive neurons (1 or 2
dendrites/neuron) from 3 different cultures were counted.
Electronic microscopy. Mice were transcardially perfused with a solu-
tion containing 4% PFA and 0.1% glutaraldehyde made up of 0.1 M PB,
pH 7.4. Brains were then immersed in the same fixative for 12 h at 4°C.
Tissue blocks containing the hippocampus were dissected and washed in
0.1 M PB, cryoprotected in 100 and 200 g/L sucrose in 0.1 M PB, and
freeze-thawed in isopentane and liquid nitrogen. Samples were postfixed
in 2.5% glutaraldehyde made up of 0.1 M phosphate buffer for 20 min,
washed and treated with 2% osmium tetroxide in PB for 20 min. They
were dehydrated in a series of ethanol and flat embedded in epoxy resin
(EPON 812 Polysciences). After polymerization, blocks from the CA1
region were cut at 70 nm thickness using an ultramicrotome (Ultracut E
Leica Microsystems). Sections were cut with a diamond knife, picked up
on formvar-coated 200 mesh nickel grids. For etching resin and remove
osmium, sections were treated with saturated aqueous sodium periodate
(NaIO4). They were then observed with a CM-100 electron microscope
(Philips) at the Institut du Fer à Moulin Cell and Tissue Imaging facility.
Digital images were obtained with a CCD camera (Gatan Orius). To test
method specificity of the immunostaining procedure, the primary anti-
body was omitted. In ultrathin sections, the density of synaptic vesicles
was calculated by counting the number of vesicles within a defined pre-
synaptic area. The area of postsynaptic densities was also evaluated. All
these calculations were performed by using the ImageJ.
Behavioral tests. To analyze mouse anxiety, we used the elevated plus
maze paradigm. Briefly, the plus maze was made of plastic and consisted
of two opposing 30  8 cm open arms, and two opposing 30  8 cm arms
enclosed by 15-cm-high walls. The maze was raised 50 cm from the floor
and lit by dim light. Each mouse was placed in the central square of the
raised plus maze, facing an open arm, and its behavior was scored for 5
min. At the end of each trial, any defecation was removed, and the appa-
ratus was wiped with 30% ethanol. We recorded the time spent in the
open arms, which normally correlates with low levels of anxiety. Animals
were tracked and recorded with SMART junior software (Panlab).
To check spontaneous locomotor activity, we used the open field.
Briefly, the apparatus consisted of a white square arena measuring 40 
40  40 cm in length, width, and height, respectively. Dim light intensity
was 60 lux throughout the arena. Animals were placed in the arena center
and allowed to explore freely for 30 min. Spontaneous locomotor activity
was measured. At the end of each trial, any defecation was removed, and
the apparatus was wiped with 30% ethanol. Animals were tracked and
recorded with SMART junior software (Panlab).
The novelty-suppressed feeding (NSF) measured the mice aversion to
eat in a novel environment. This test assesses stress-induced anxiety by
measuring the latency of an animal to approach and eat a familiar food in
an aversive environment. For this task, mice were food-restricted for a
period of 24 h. After food restriction, the animals were placed in a large,
brightly lit, open field. A piece of white filter paper was placed in the
center of the arena with a small piece of rodent chow. The time to ap-
proach and eat a pellet of food located in the center of the arena was
measured and used to evaluate anxiety-like behavior.
The forced swimming test was used to evaluate behavioral despair.
Animals were subjected to a 6 min trial during which they were forced to
swim in an acrylic glass cylinder (35 cm of height  20 cm of diameter)
filled with water, and from which they could not escape. The time that the
test animal spent in the cylinder without making any movements beyond
those required to keep its head above water was measured.
The spontaneous alternation performance was tested using a sym-
metrical Y-maze. Each mouse was placed in the center of the Y-maze
and could explore freely through the maze during an 8 min session.
The sequence and total number of arms entered were recorded. Arm
entry was complete when the hindpaws of the mouse had been com-
pletely placed in the arm. Percentage alternation is the number of
triads containing entries into all three arms divided by the maximum
possible alternations (the total number of arms entered  2)  100.
As the reentry into the same arm was not counted for analysis, the
chance performance level in this task was 50% in the choice between
the arm mice visited more recently (nonalternation) and the other
arm visited less recently (alternation).
The novel object location memory task evaluates spatial memory and
is based on the ability of mice to recognize when a familiar object has
been relocated. Exploration took place in an open-top arena with quad-
rangular form (45  45 cm). The light intensity was 40 lux throughout
the arena. Mice were first habituated to the arena in the absence of objects
(1 d, 30 min). Some distal cues were placed throughout the procedure.
On the third day during the acquisition phase, mice could explore two
duplicate objects (A1 and A2), which were placed close to the far corners
of the arena for 10 min. After a delay of 24 h, one object was placed in the
diagonally opposite corner. Thus, both objects in the phase were equally
familiar, but one was in a new location. The position of the new object
was counterbalanced between mice. Animals were tracked and recorded
with SMART Junior software (Panlab).
For the passive avoidance (light-dark) paradigm, we conducted the
experiments in a 2-compartment box, where 1 compartment was dimly
lit (20 lux) and preferable to a rodent and the other compartment was
brightly lit (200 lux); both chambers were connected by a door (5 cm 
5 cm). During training, mice were placed into the aversive brightly lit
compartment; and upon the entry into the preferred dimly lit compart-
ment (with all 4 paws inside the dark chamber), mice were exposed to a
mild foot shock (2 s foot shock, 1 mA intensity). The latency of mice to
enter into the dark chamber was recorded. Twenty seconds after receiv-
ing the foot shock, mice were returned to the home cage until testing.
After 24 h (long-term memory), animals were tested for retention. In the
retention test, mice were returned to the brightly lit compartment again,
and the latency to enter the shock paired compartment (dark chamber)
was measured (retention or recall latency). Ten minutes was used as a
time cutoff in the retention test. The animals that learned the task would
avoid the location previously paired with the aversive stimulus and
showed a greater latency to enter it.
In vivo electrophysiological recordings. Animals were anesthetized with
0.8%–1.5% isoflurane (Astra Zeneca) delivered via a special mask (Cib-
ertec). Once anesthetized, animals were implanted with bipolar stimu-
lating electrodes aimed at the right Schaffer collateral-commissural
pathway of the dorsal hippocampus (2 mm lateral and 1.5 mm posterior
to bregma; depth from brain surface, 1.0 –1.5 mm) (Paxinos and Frank-
lin, 2013) and with a recording electrode aimed at the ipsilateral stratum
radiatum underneath the CA1 area (1.2 mm lateral and 2.2 mm posterior
to bregma; depth from brain surface, 1.0 –1.5 mm) (Paxinos and Frank-
lin, 2013). Stimulating and recording electrodes were made of 50 m,
Teflon-coated tungsten wire (Advent Research Materials). The final lo-
cation of the recording electrode in the CA1 area was determined follow-
ing the field potential depth profile evoked by paired (40 ms interval)
pulses presented to the ipsilateral Schaffer collateral pathway (Gruart et
al., 2006). Two bare silver wires were affixed to the skull as ground.
Electrodes were connected to a 6-pin socket (RS-Amidata) that was lat-
terly fixed with dental cement to the cranial bone. After surgery, each
animal was kept in an independent cage with free access to food and
water for the rest of the experiment.
Recording sessions were started 1 week after surgery. Electrophysio-
logical recordings were performed using Grass P511 differential amplifi-
ers with a bandwidth of 0.1–10 kHz (Grass-Telefactor). Electrical
stimulation was provided by a CS-220 stimulator across CS-220 isolation
units (Cibertec). For input/output curves, monosynaptic fEPSPs were
evoked in the CA1 area by single (100 s, square, and negative-positive)
pulses applied to Schaffer collaterals. These pulses were presented at
increasing intensities ranging from 20 to 400 A, in steps of 20 A. To
avoid interactions with the preceding stimuli, an interval of 30 s was
allowed between each pair of pulses (Madroñal et al., 2007).
For the characterization of the paired-pulse facilitation at the CA3-
CA1 synapse, we used the same type of pulses indicated above, but pre-
sented in pairs at increasing interpulse intervals (10, 20, 40, 100, 200, and
500 ms). For each animal, the stimulus intensity was set at 30%– 40% of
the intensity necessary for evoking a maximum fEPSP response (Gurevi-
ciene et al., 2004; Gruart et al., 2006). Intervals between pairs of pulses
were set at 30 s, to avoid unwanted interactions evoked by presynaptic
or postsynaptic mechanisms.
LTP experiments were also performed in alert behaving animals.
fEPSPs were evoked at the CA3-CA1 synapse for 15 min before LTP
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induction. For this, single pulses were presented at a rate of 3 per min.
The stimulus intensity was set at 30%– 40% of the intensity necessary
for evoking a maximum fEPSP response, namely, well below the
threshold for evoking a population spike (Gruart et al., 2006; Madro-
ñal et al., 2007). For LTP induction, each animal was subjected to a
high-frequency stimulation (HFS) protocol consisting of five 200 Hz,
100 ms trains of pulses at a rate of 1 per second. This protocol was
presented six times, at intervals of 1 min. The HFS protocol used here
(combining low intensity values and a total of 600 electric shocks)
allowed us to evoke LTP lasting 2–3 d, without the appearance of
abnormal spikes in EEG recordings and/or overt epileptic seizures
(Madroñal et al., 2009). Following the HFS session, animals were
stimulated again with single pulses applied for 60 min at the same rate
of 3 per min. Additional 30 min recordings of fEPSPs were repeated
for 3 d following the HFS session.
Experimental design and statistical analysis. All data are expressed as
mean  SEM. Statistical analysis was performed using the unpaired two-
sided Student’s t test (95% confidence), one-way ANOVA with the
Tukey’s as post hoc tests, or two-way ANOVA with the Bonferroni’s post
hoc test as appropriate and indicated in the figure legends. Values of p 
0.05 were considered statistically significant.
All experiments in this study were blinded and randomized. All mice
bred for the experiments were used for preplanned experiments and
randomized to experimental groups. Visibly sick animals were excluded
before data collection and analysis. Data were collected, processed, and
analyzed randomly. The experimental design and handling of mice were
identical across experiments. Littermates were used as controls with mul-
tiple litters (3–5) examined per experiments. All mice were bred in the
Institut du Fer à Moulin Animal Facility.
Results
Astrocytes BDNF production regulates cultured hippocampal
neurons morphology and dendritic spine density
Although BDNF is mainly produced in neurons, it is also local-
ized in astrocytes (Saha et al., 2006; Giralt et al., 2010). We veri-
fied that this was the case in our experimental conditions using
RT-PCR to detect BDNF transcripts (3745  1125% increase,
p 	 0.0468) (Fig. 1A). However, the precise role of BDNF from
astrocytes in neuronal function is still unclear. We evaluated
whether BDNF derived from astrocytes was physiologically rele-
vant for neuronal dendrite morphology. We cultured primary
astrocytes from mouse pups lacking the BDNF gene (BDNF/
pups) or WT littermates as a control (BDNF/ pups). After
astrocyte 100% confluence, we seeded primary WT neurons at
E17 on the top of the astrocyte monolayer (Fig. 1B). Then, some
astrocyte-neuron cocultures were fixed at 6 DIV to evaluate the
morphological characteristics of the imaged neurons stained for
MAP2 by using the Sholl analysis (Fig. 1C). The results indicated
that the number of intersections in WT neurons grown on
BDNF/ astrocytes were reduced compared with WT neurons
on BDNF/ astrocytes (Fig. 1D). We fixed other astrocyte-
neuron cocultures at 20 DIV, transfected 48 h before fixation with
a GFP-expressing construct (see Material and Methods). We thus
were able to evaluate spine density in isolated MAP2-positive
neurons. We observed that the number of spines in WT neurons
cocultured with BDNF/ astrocytes was decreased compared
with neurons cocultured with BDNF/ astrocytes (0.2555 
0.046 decrease, p  0.0001) (Fig. 1E). These results reveal a cru-
cial role of BDNF released from astrocytes in the modulation of
neurons, particularly in dendrite and spine development, in co-
culture conditions. They provide a rationale for the use of astro-
cytes to overexpress BDNF in brain locations with high levels of
pathology in AD.
Generation and characterization of the 5xFAD mice
overexpressing BDNF under the GFAP promoter
To test the potential role of astrocyte-derived BDNF in an AD
mouse model, we then took advantage of mice that overexpress
BDNF under the control of the GFAP promoter (pGFAP-BDNF
mice) (Giralt et al., 2010). In these mice, BDNF production and
delivery are increased in neuropathological conditions accompa-
nied by astrogliosis (Giralt et al., 2010, 2011). We crossed
pGFAP-BDNF mice with the 5xFAD transgenic mouse model of
AD to create 5xF:pGB mice. The 5xFAD mice develop severe
amyloid pathology and associated astrogliosis at 1.5–2 months of
age, before the onset of the cognitive deficits (observed at 4
months of age) (Oakley et al., 2006). A significant decrease in
BDNF levels is also observed in 5xFAD mice (Hongpaisan et al.,
2011). We predicted that this decrease would be prevented in the
5xF:pGB double-transgenic mice. To test this hypothesis, we an-
alyzed BDNF hippocampal levels in WT, pGFAP-BDNF, 5xFAD,
and 5xF:pGB mice at 8 months of age, when their phenotype is
clear. At this age, astrogliosis was obvious throughout the hip-
pocampus, as evidenced by immunofluorescence (Fig. 2A) and
Western blot (146  18 increase, p  0.001) (Fig. 2B,C). As
expected, BDNF levels were reduced (58  17 decrease, p 
0.05) in the hippocampus of 5xFAD mice compared with WT
mice (Fig. 2B,D). Interestingly, BDNF levels in the hippocampus
of 5xF:pGB mice were undistinguishable from those in WT mice,
indicating a full recovery of BDNF protein levels in this group of
mice. We next studied whether such recovery correlated with an
improvement in the BNDF-TrkB downstream signaling. We
performed Western blot analyses to measure total and phos-
phorylated levels of ERK, Akt and, PLC, which are key pro-
teins in the three major signaling pathways downstream of
BDNF-TrkB (Gupta et al., 2013). Total levels of ERK, Akt, and
PLC were similar in all the four groups of mice (Fig. 2E).
Phosphorylation levels of ERK threonine/tyirosine 202/204
and PLC tyrosine 783 were decreased in the hippocampus of
5xFAD mice (ERK T202/Y204: 69  8.5 decrease, p  0.001;
PLC Y783: 40  17 decrease, p  0.05), whereas Akt serine
308 phosphorylation was not significantly affected (Fig.
2 E, F ). In 5xF:pGB mice, phosphorylation of ERK and PLC
was like that in WT mice. Interestingly, in 5xF:pGB mice, the
phosphorylated levels of ERK and PLC were similar to those
in WT mice. No changes in these phosphoproteins were ob-
served in the WT mice expressing the pGFAP-BDNF transgene
(Fig. 2 E, F ), supporting the specificity of the astrocyte-
dependent BDNF expression. These results indicate that the
5xF:pGB mice develop a significant astrogliosis, which, in
turn, induces an overproduction of BDNF from astrocytes
preventing the loss of BDNF/TrkB function due to the effects
of APP695 and PSEN-1 transgenes. Furthermore, normaliza-
tion of BDNF levels in the 5xF:pGB mice was accompanied by
a complete restoration of BDNF-TrkB downstream signaling.
Rescue of memory alterations in 5xF:pGB mice
The 5xFAD transgenic mice display a strong phenotype with a
relatively fast time course compared with other AD mouse models.
At 8 months of age, they display decreased locomotor activity, al-
tered performance in the elevated plus maze, and memory deficits in
hippocampal-related tasks, such as the Y-maze and the novel object
location (Oakley et al., 2006; Devi and Ohno, 2015; Schneider et al.,
2015; Grinan-Ferre et al., 2016). The passive avoidance, which is also
affected in other mouse models of AD (Webster et al., 2014), has not
been reported in 5xFAD, to our knowledge. Furthermore, AD pa-
tients exhibit high comorbidity with depressive symptoms (Webster
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Figure 1. BDNF regulates dendrites and spine number in vitro. A, Left, BDNF mRNA levels were determined in WT astrocytes. HEK293 cells were used as negative control (Student’s t test, t 	
2.496, df 	 6; p  0.05; n 	 3–5). Right, Representative agarose gel. Arrow indicates the molecular weight of the BDNF transcript detected at 114 bp. B, The experimental design is depicted
illustrating the two in vitro conditions: BDNF / astrocyte monolayer cocultured with WT neurons (i.e., BDNF /) and BDNF / astrocyte monolayer cocultured with WT neurons (i.e.,
BDNF /). C, Representative images showing the bright-field allowing visualization of the astrocyte monolayer plus some cocultured neurons on the top, hippocampal neurons stained for MAP2
(red), and transfected MAP2-positive neurons transfected with a plasmid coding GFP (green). D, Representative MAP2 images obtained by confocal microscopy from cocultured astrocytes and
neurons (top). Scale bar, 40 m. Bottom, Sholl analysis from MAP2-positive neurons (two-way ANOVA analysis; group effect, F(1,307) 	 81.7, p  0.001). E, Spine density was studied using GFP
fluorescence in transfected MAP2-positive neurons (left). Quantification of spine density (right) is shown (Student’s t test, t 	 5.462, df 	 70; p  0.001). Data are mean  SEM. D, n 	 45 and
60 MAP2-positive neurons/group from 3 different experiments. E, n 	 31 and 41 *dendrites/group from 3 different experiments. ***p  0.001 as compared to BDNF / mice.
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Figure 2. Validation of the 5xF:pGB model. Crossing 5xFAD mice with pGFAP-BDNF mice resulted in four genotypes, namely, WT, pGFAP-BDNF, 5xFAD, and the double-mutant 5xF:pGB mice. We
evaluated these mice at 8 months of age. A, GFAP immunofluorescence microscopy imaging in the dorsal hippocampus of 8-month-old WT, pGFAP-BDNF, 5xFAD, and 5xF:pGB mice. Scale bar, 500
m. B, Immunoblotting for BDNF, GFAP, and tubulin as a loading control in the hippocampus of 8-month-old WT, pGFAP-BDNF, 5xFAD, and 5xF:pGB mice. C, Densitometry quantification of BDNF
levels as in B. D, Densitometry quantification of GFAP levels as in B. One-way ANOVA, BDNF genotype effect: F(3,24) 	 4.403, p 	 0.0103; GFAP genotype effect: F(3,25) 	 41.18, p  0.001. Data
were normalized to tubulin for each sample and expressed as a percentage of WT. E, Immunoblotting for pAkt ser308, pERK T402/Y404, pPLC Y783, ERK, Akt, and PLC and tubulin as a loading control
in the hippocampus of 8-month-old WT, pGFAP-BDNF, 5xFAD, and 5xF:pGB mice. F, Densitometry quantification of pAkt ser308, pERK T402/Y404, and pPLC Y783 levels as in E. One-way ANOVA,
pERK T402/Y404 genotype effect: F(3,28) 	 29.14, p  0.001; pAkt
ser308 genotype effect: F(3,26) 	 0.5666, p  0.646; pPLC
Y783 genotype effect: F(3,28) 	 5.251, p  0.0053. Data were normalized
to the corresponding total levels of ERK, Akt, and PLC for each sample and expressed as a percentage of WT. Data are mean  SEM. C–F, Tukey’s test as a post hoc analysis was used. *p  0.05;
***p  0.001; compared with WT mice. $$p  0.01; $$$ p  0.001; compared with 5xFAD mice. B, E, Molecular weight markers positions are indicated in kDa. C–F, n 	 6 –11/group.
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Figure 3. Characterization of 5xF:pGB mice. A, WT, pGFAP-BDNF, 5xFAD, and mice at 8 months of age were subjected to a comprehensive behavioral characterization. In the open field, (A)
locomotor activity and (B) time spent in the center of the arena were monitored for 30 min in WT, pGFAP-BDNF, 5xFAD, and 5xF:pGB mice. Locomotor activity, two-way ANOVA, genotype effect:
F(3,116) 	 1.2654, p 	 0.2899; time in center, one-way ANOVA: F(3,80) 	 1.009, p 	 0.3934. C, In the plus maze, the time spent in the open arms was monitored for 5 min in the four groups of mice.
One-way ANOVA: F(3,77) 	 6.907, p 	 0.005. D, In the NSF test, the time to reach and eat the pellet in the center of the arena was evaluated in the four genotypes. One-way ANOVA: F(3,76) 	 1.467,
p 	 0.2303. E, In the forced swimming test, the immobility time was evaluated during the last 4 min of the 6 min trial in all groups. One-way ANOVA: F(3,80) 	 0.9903, p 	 0.417. F, In the novel
object location test, spatial long-term memory was evaluated 24 h after a training trial as the percentage of time exploring the object placed in a new location (NL) (Figure legend continues.)
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et al., 2014) and depressive behaviors have been reported at least in
one mouse model of AD (Filali et al., 2009).
To evaluate the potential beneficial effects of reactive
astrocytes-targeted BDNF expression in 5XFAD mice, we char-
acterized all these behavioral parameters. We first evaluated the
basal locomotor activity and anxiety in the open field in WT,
pGFAP-BDNF, 5xFAD, and 5xF:pGB mice. All groups of mice
displayed a similar initial habituation and comparable levels of
locomotor activity (Fig. 3A) and time spent in the center (Fig.
3B). Next, we investigated anxiety by performing the elevated
plus maze and the NSF tests. In the elevated plus maze, both
5xFAD mice (18.45  6.6 increase, p  0.05) and 5xF:pGB mice
(23.50  6.92 increase, p  0.01) spent more time in the open
arms than WT and pGFAP-BDNF mice (Fig. 3C), but there were
no differences between 5xFAD and 5xF:pGB mice. In the NSF,
the mice from all four groups showed similar latencies to feed in
the aggressive environment (Fig. 3D). We also tested the behav-
ioral resignation in the four groups of mice by performing the
forced swimming test. The amount of time during which the
mice were swimming trying to escape from the water was similar
in all mice, independently of their genotype (Fig. 3E). These re-
sults indicate that 5XFAD mice displayed only minor anxiety or
mood-related alterations, with only an apparent decrease in anx-
iety in the elevated plus maze, which was not modified by BDNF
overexpression.
We next studied memory in these mice. First, we evaluated
spatial memory in the novel object location test, which is based
on the ability of rodents to recognize when a familiar object has
been relocated. After habituation to the open field arena, mice
were trained in the presence of 2 identical objects (A1 and A2),
and spatial memory was assessed 24 h later by displacing one of
the two objects. 5xFAD mice exhibited a significantly lower pref-
erence for the displaced object compared (1.877  5.64, not sig-
nificant between old location and new location) with either WT
or pGFAP-BDNF mice (Fig. 3F). The spatial memory deficit was
prevented in the 5xF:pGB mice (Fig. 3F). Next, mice were tested
in the spontaneous alternation Y-maze paradigm that assesses
spatial working memory (Lalonde, 2002). The spontaneous alter-
nation behavior relies on the tendency of mice to enter a less
recently visited arm compared with the other one. WT and
pGFAP-BDNF mice displayed a spontaneous alternation,
whereas the arm choice was decreased to 50% (chance levels) in
the 5xFAD mice (12.70  3.27 decrease, p  0.01) (Fig. 3G).
The spontaneous alternation was restored to WT control levels in
5xF:pGB mice. Finally, we examined associative memory in the
passive avoidance task, based on the association formed between
an electrical foot shock and a spontaneously preferred specific
environmental context (darkness vs light). Latency to step-
through during the training session was similar between geno-
types (Fig. 3H). However, in the testing session, although all
genotypes showed a significant increase in the latency to enter the
dark compartment 24 h after receiving an electrical shock (wt:
255  39 increase, p  0.001; pGFAP-BDNF: 192  32 increase,
p  0.001; 5xFAD 78.8  28 increase, p  0.05; 5xF:pGB: 145 
35 increase p  0.001), this latency was shorter in mutant 5xFAD
mice compared with WT (178  34 decrease, p  0.001) or
pGFAP-BDNF mice (117.70  30 decrease, p  0.01) (Fig.
3H). This alteration was absent in double-mutant 5xF:pGB mice
(Fig. 3H). The results of the novel object location, spontaneous
alternation, and passive avoidance tests demonstrate that tar-
geted increased expression of BDNF prevented several memory
deficits in 5xFAD mice.
Normalization of BDNF levels in double-mutant 5xF:pGB
mice does not prevent plaque formation and neurogenesis
deficits
To test whether the restoration of BDNF levels modulated
-amyloidosis in 8-month-old 5xFAD mice, toluidine blue stain-
ing was performed to determine the number of plaques in the
hippocampus and PFC of 5xFAD and 5xF:pGB mice (Fig. 4A).
The cortical plaque load in 5xF:pGB mice was indistinguishable
from that in age-matched 5xFAD control mice. However, in the
hippocampus, we detected an increase in the number of plaques
in 5xF:pGB mice compared with 5xFAD mice (0.3507  0.0469
increase, p 	 0.017) (Fig. 4B). We hypothesized that the size of
the plaques could be different between genotypes, indicating dif-
ferent dynamics in -amyloidosis. To test this possibility, we
characterized the plaques in the hippocampus of 5xFAD and 5xF:
pGB mice by using electron microscopy (Fig. 4C). Ultrastructural
analysis revealed that hippocampal plaques in 5xF:pGB mice
were visually more compact but significantly smaller than the
plaques in 5xFAD mice (131  27 decrease, p 	 0.015) (Fig.
4C,D), supporting the hypothesis that -amyloid accumulation
in 5xF:pGB mice is different compared with that in 5xFAD mice.
Because findings on hippocampal plaque quantification ap-
peared inconsistent with memory improvements, we then evalu-
ated the rate of newborn cells in the dentate gyrus, whose deficits
have been previously reported to be associated with cognitive
impairments (Moon et al., 2014). We counted the number of
Ki67-positive cells in the dentate gyrus of the four groups of mice.
A significant decrease in the number of newborn cells was ob-
served in the dentate gyrus of both 5xFAD (5  1.69 decrease,
p  0.05) and 5xF:pGB (5.26  1.84 decrease, p  0.05) mice
compared with WT or pGFAP-BDNF mice (Fig. 4E,F). These
data indicate that normalizing BDNF levels in 5xF:pGB mice is
not enough to prevent the alterations in neurogenesis observed in
5xFAD mice.
Normalization of BDNF levels in double-mutant 5xF:pGB
mice restores dendritic spines and synaptic alterations
Because BDNF normalization did not improve neuropathologi-
cal hallmarks in 5xFAD mice, including astrogliosis (Fig. 2A–C),
plaque number (Fig. 4A,B), and neurogenesis deficit (Fig. 4E,F),
we assumed that phenotypic improvements observed in 5xF:pGB
mice could be related with synaptic changes. To test this hypoth-
esis, we performed Golgi staining in two different brain regions in
all 4 genotypes at the age of 8 months to examine dendritic spine
density and morphology in pyramidal neurons. We examined the
cortical layer V in the PFC and the stratum radiatum of CA1.
First, we observed that spine density in secondary dendrites of
cortical pyramidal neurons was significantly decreased in 5xFAD
mice compared with WT mice (0.231  0.034 decrease, p 
0.001) (Fig. 5A,B). This decrease was partially rescued in 5xF:
4
(Figure legend continued.) versus the time exploring the object placed in an old location (OL).
Two-way ANOVA, object in a new location effect: F(3,150) 	40.80, p0.001. Interaction effect:
F(3,150) 	 7.14, p 	 0.002. G, In the Y-maze, the spontaneous alternation was measured (as
triads) in an 8 min trial in all four genotypes. One-way ANOVA: F(3,44) 	 7.717, p 	 0.003. H, In
the passive avoidance paradigm, the latency (seconds) to step-through was evaluated in the
training trial and in the testing trial 24 h after receiving an electric shock (2 s/1 mA). One-way
ANOVA: F(3,126) 	 5.384, p 	 0.0016. Data are mean  SEM. A, B, H, n 	 18 –25 mice/
genotype. G, n 	 12–14 mice/genotype. Tukey’s post hoc test was used for all behavioral tasks.
C, G, H, *p  0.05; **p  0.01; ***p  0.001; compared with WT. $p  0.05; $$p  0.01;
compared with 5xFAD. F, *p  0.05; ***p  0.001; compared with percentage of time explor-
ing the object in an old location (OL).
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Figure 4. Analysis of gross neuropathology and neurogenesis in WT, pGFAP-BDNF, 5xFAD, and 5xF:pGB mice. A, Amyloid plaques images stained with blue toluidine obtained in a bright-field
microscope in the frontal cortex (top left) and in the hippocampus (bottom left) of 5xFAD and 5xF:pGB mice at 8 months of age. Scale bar, 400 m. B, The plaque density was determined by manual
counting in the PFC and in the hippocampus of all four genotypes (right). Student’s unpaired t test: PFC, t 	 1.923, df 	 4, p 	 0.1268; hippocampus, t 	 7.446, df 	 4, p 	 0.0017. C, Amyloid
plaque images obtained with electronic microscopy (left). Plaques have been colorized for easy visualization for the reader. Black arrows indicate the plaque boundary. D, The hippocampal plaque
area was determined by using the ImageJ software (right). Scale bar, 10 m. Student’s unpaired t test: t	4.743, df	8, p	0.0015. E, Ki67-positive cells obtained by confocal microscopy imaging
in the dentate gyrus in 8-month-old WT, pGFAP-BDNF, 5xFAD, and 5xF:pGB mice (left). Scale bar, 300 m. F, Quantification of the number of the Ki67-positive cells per (Figure legend continues.)
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pGB mice (0.089  0.036 decrease, p  0.05) (Fig. 5A,B).
Then, we analyzed spine morphology and the density of the three
different spine types (mushroom, thin, and stubby) in the same
pyramidal neurons (Fig. 5C). No differences were observed in the
density of stubby spines, whereas thin spines were markedly de-
creased in 5xFAD mice (0.108  0.021 decrease, p  0.001) and
completely recovered in 5xF:pGB mice (Fig. 5C). In contrast,
mushroom spines were decreased equally in 5xFAD (0.098 
0.021 decrease, p  0.001) and in 5xF:pGB (0.067  0.023
decrease, p  0.05) mice compared with WT and pGFAP-BDNF
mice. These results revealed that overexpression of astrocytic
BDNF in 5xF:pGB mice specifically rescued thin spines but not
mushroom spines in the PFC.
Next, we examined the same parameters in CA1 pyramidal
neurons in the four genotypes. Spine density was decreased in
5xFAD mice compared with WT mice (0.132  0.046 decrease,
p  0.05), and this decrease was rescued in 5xF:pGB mice (Fig.
5D,E). When we analyzed spine morphology, we detected a small
decrease in stubby spine density only in 5xF:pGB compared with
WT mice (0.076  0.048 decrease, p  0.05) whose meaning is
uncertain (Fig. 5F). In contrast, a clear decrease in thin spines
density was observed in 5xFAD compared with WT mice
(0.100  0.026 decrease, p  0.01) that was rescued in 5xF:pGB
mice (Fig. 5F). Finally, no changes in the density of mushroom
spines were detected in any group. These results show that the
main alteration in both PFC and hippocampal CA1 region was a
decrease in thin spines in 5xFAD mice which was rescued in
5xF:pGB mice.
To explore changes in excitatory synapses likely associated
with spine alterations, we evaluated presynaptic and postsynaptic
markers. We examined the number of positive clusters for
PSD-95 and synaptophysin, which are postsynaptic and presyn-
aptic markers, respectively, previously reported to be decreased
in 5xFAD mice, correlating with cognitive decline (Yang et al.,
2015; Giralt et al., 2018). We analyzed these two markers in CA1
stratum radiatum of 8-month-old mice. As expected, the number
of PSD-95-positive puncta was decreased in 5xFAD compared
with WT mice (754  125 decrease, p  0.001) (Fig. 6A,B).
This decrease was rescued in 5xF:pGB mice (Fig. 6A,B). The
number of synaptophysin-positive puncta was also decreased in
CA1 stratum radiatum of 5xFAD compared with WT mice
(685  190 decrease, p  0.05) (Fig. 6C,D). Synaptophysin
puncta were recovered in 5xF:pGB mice. Together, these results
suggest that the behavioral improvement observed in 5xF:pGB
mice compared with 5xFAD mice was accompanied by an im-
provement in the clusters of presynaptic and postsynaptic mark-
ers, indicative of actual synapses. Additionally, we evaluated
whether these changes were associated with direct TrkB-
mediated signaling in neurons. To do so, we counted the number
of double-labeled PSD-95/phospho-TrkB Y816-positive puncta in
the CA1 stratum radiatum of 8-month-old mice. We observed
that 5xFAD mice displayed a reduction of double-labeled PSD-
95/phospho-TrkB Y816-positive puncta in the stratum radiatum
(65  20 decrease, p  0.05), whereas such parameter was fully
recovered in 5xF:pGB mice (Fig. 6E,F), indicating that 5xF:pGB
mice improvements were associated with a TrkB-dependent sig-
naling recovery in neurons. Next, to further examine presynaptic
and postsynaptic changes, we performed electronic microscopy
experiments and analyzed the PSD area and the number of pre-
synaptic vesicles per synapse, in the CA1 stratum radiatum of the
four groups of mice at 8 months. We observed no alteration of the
PSD area in 5xFAD mice but an unexpected increase in pGFAP-
BDNF controls (0.0059  0.00089 increase, p  0.001) (Fig.
6G,H). Conversely, the number of presynaptic vesicles per syn-
apse was significantly decreased in 5xFAD mice (5.088  1.046
decrease, p  0.001) but was completely rescued in 5xF:pGB mice
(Fig. 6G,I). These results on spines, synaptic marker clusters, and
synaptic vesicles suggest that the cognitive improvements ob-
served in 5xF:pGB mice resulted from synaptic improvements.
In vivo study of electrophysiological properties of the
CA3-CA1 synapses in 5xF:pGB mice
To determine whether the rescue of histological alterations fol-
lowing BDNF astrocytic expression was associated with func-
tional improvements, we studied the in vivo electrophysiological
properties of hippocampal circuits in the four groups of mice. We
recorded input/output curves, paired-pulse facilitation, and LTP
evoked at the CA3-CA1 synapses (Fig. 7A–C).
We first analyzed the response of CA1 pyramidal neurons to
single pulses of increasing intensity (0.02– 0.4 mA) presented to
the ipsilateral Schaffer collaterals. As illustrated in Figure 7D, the
four groups (wt, n 	 13; pGFAP-BDNF, n 	 15; 5xFAD, n 	 11;
5xF:pGB, n 	 13) presented similar increases (F(57,912) 	 1.460;
p  0.017; two-way repeated-measures ANOVA) in the slope of
fEPSP evoked in CA1 by stimuli presented to the ipsilateral Schaf-
fer collaterals. No significant differences (F(3,912) 	 0.718; p 	
0.546) between the four collected curves were observed. These
two relationships were best fitted by sigmoid curves (r  0.99;
p  0.0001; not illustrated), suggesting a normal basal function of
the CA3-CA1 synapses in the four mouse genotypes.
Changes in synaptic strength evoked by a pair of pulses are a
form of presynaptic short-term plasticity, mostly related to vari-
ations in neurotransmitter release (Zucker and Regehr, 2002). In
this regard, paired-pulse stimulation is commonly used as an
indirect measurement of changes in the probability of neurotrans-
mitter release at presynaptic terminals of hippocampal synapses
(Zucker and Regehr, 2002). In addition, it has been shown that these
synaptic properties can be studied in alert behaving mice (Madroñal
et al., 2009). The paired-pulse facilitation evoked in the four groups
(wt, n 	 15; pGFAP-BDNF, n 	 19; 5xFAD, n 	 13; 5xF:pGB, n 	
14) was analyzed presenting a fix stimulus intensity (30%–40% of
asymptotic values) with increasing interpulse intervals (see Materials
and Methods). As illustrated in Figure 7E, the four groups of mice
presented a paired-pulse facilitation at short (10, 20, and 40 ms)
interpulse intervals (F(5,240) 	 21.290; p  0.001). However, no sig-
nificant differences were observed between groups (F(15,240) 	0.464;
p 	 0.956).
Finally, we performed an LTP study in the four groups of
behaving mice. It is generally accepted that CA3-CA1 synapses
are involved in the acquisition of different types of associative
(classical eye blink conditioning) and nonassociative (object rec-
ognition, spatial orientation) learning tasks, and it is usually se-
lected for evoking LTP in behaving mice (Gruart et al., 2006). For
baseline values, animals were stimulated at the implanted Schaf-
fer collaterals 3 times/min for 15 min (Fig. 7F). Then, animals
(wt, n 	 16; pGFAP-BDNF, n 	 19; 5xFAD, n 	 13; 5xF:pGB,
n 	 14) were presented with the selected HFS protocol (Fig. 7F,
dashed line). Following HFS, the same single stimulus used to
4
(Figure legend continued.) field (right). Genotype effect: F(3,20) 	 5.323, p  0.0073. Data
are mean  SEM. B, D, Student’s unpaired t test. F, One-way ANOVA and Tukey’s post hoc test.
B, D, *p  0.05; **p  0.01; compared with 5xFAD mice. F, *p  0.01; compared with WT
mice. B, n 	 4 mice/genotype. D, n 	 4 mice/genotype. F, n 	 6 or 7 mice/genotype. Ctx,
Frontal cortex; Hipp, hippocampus.
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generate baseline records was presented at
the initial rate (3/min) for another 60 min.
Recording sessions were repeated for
three additional days (30 min each; Fig.
7F). The four groups of mice presented a
significant increase in fEPSP slopes fol-
lowing the HFS session (F(114,1976) 	
1.863; p  0.001). Nevertheless, a point-
to-point comparison between fEPSPs
evoked in the four groups of mice after the
HFS protocol indicated that 5xF:pGB an-
imals presented larger LTP values for the
first recording session (p  0.045) than
the three other groups.
Figure 7F (inset) illustrates the evolu-
tion of paired-pulse facilitation in the four
groups of mice. In accordance with previ-
ous descriptions (Madroñal et al., 2009),
and as observed here for WT, pGFAP-
BDNF, and 5xF:pGB mice, paired-pulse
facilitation decreased immediately after
HFS and was recovered in the following
days. Interestingly, the 5xFAD group did
not show any sign of recovery of paired-
pulse facilitation for the four recording
days after the HFS session, indicating an
increase in the response to the first pulse
in this stressful situation.
In conclusion, the four groups of mice
presented similar basal synaptic proper-
ties and short-term plasticity. Interest-
ingly, although the four groups of mice
presented a significant LTP with respect to
baseline values, LTP was significantly
larger in the 5xF:pGB group than in the
other three groups during the first record-
ing session following the HFS protocol.
The 5xFAD group presented LTP values
like those reached by WT and pGFAP-
BDNF group; this result could be ascribed
to an increase in neurotransmitter release
evoked by a first pulse because their
paired-pulse facilitation was decreased
Figure 5. Dendritic spine density and morphology analysis in the PFC and hippocampus of WT, pGFAP-BDNF, 5xFAD, and
5xF:pGB mice. A, Images of apical dendrites from pyramidal neurons of the layer V in PFC stained with Golgi staining obtained in a
bright-field microscope in 8-month-old WT, pGFAP-BDNF, 5xFAD, and 5xF:pGB mice. Scale bar, 5 m. B, The dendritic spine
density was determined in all four genotypes by using the ImageJ freeware. One-way ANOVA: F(2,100) 	 23.09, p  0.001. C,
Density of each type of dendritic spine (stubby, thin, and mushroom) in apical dendrites of pyramidal neurons of the layer V of the
PFC in 8-month-old WT, pGFAP-BDNF, 5xFAD, and 5xF:pGB mice. Two-way ANOVA, genotype effect: F(3,390) 	 21.83, p  0.001;
4
interaction effect, F(3,390) 	 6.036, p  0.001. D, Images of
apical dendrites from pyramidal neurons of the hippocampal
CA1 stained with Golgi staining obtained in a bright-field mi-
croscope in 8-month-old WT, pGFAP-BDNF, 5xFAD, and 5xF:
pGB mice. Scale bar, 5 m. E, The dendritic spine density was
determined in all four genotypes by using the ImageJ free-
ware. One-way ANOVA: F(3,185) 	 4.070, p 	 0.0079. F, Den-
sity of each type of dendritic spine (stubby, thin, and
mushroom) in apical dendrites of pyramidal neurons from the
hippocampal CA1 in 8-month-old WT, pGFAP-BDNF, 5xFAD,
and 5xF:pGB mice. Two-way ANOVA, genotype effect: F(3,552)
	3.678, p	0.0121; interaction effect, F(3,390) 	2.750, p	
0.0122. Data are mean  SEM. B, E, One-way ANOVA with
Tukey’s test as a post hoc was used. C, F, Two-way ANOVA and
Bonferroni’s post hoc test. B, C, E, F, *p  0.05; **p  0.01;
***p  0.001; compared with WT mice. $p  0.05; $$p 
0.01; $$$p  0.001; compared with 5xFAD mice. B, C, n 	
31– 41 dendrites/genotype (from 5 mice/genotype). E, F, n 	
35–56 dendrites/genotype (from 5 mice/genotype).
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Figure 6. Hippocampal excitatory synapse characterization of WT, pGFAP-BDNF, 5xFAD, and 5xF:pGB mice. A, Confocal image of PSD-95 immunofluorescence in CA1 stratum radiatum of
8-month-old WT, pGFAP-BDNF, 5xFAD, and 5xF:pGB mice. Scale bar, 10 m. B, Quantification of the number of PSD-95-positive puncta per field. One-way ANOVA: F(3,16) 	 14.90, p  0.001. C,
Synaptophysin immunofluorescence. Scale bar, 10 m. D, Quantification of the number of synaptophysin-positive puncta per field. One-way ANOVA: F(3,16) 	 7.194, p  0.0028. E, Confocal image
of a double PSD-95 (green) and phosphoTrkB Y816 (red) immunofluorescence in CA1 stratum radiatum of 8-month-old WT, pGFAP-BDNF, 5xFAD, and 5xF:pGB mice. (Figure legend continues.)
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and remained in this situation across the four recording sessions
after HFS.
Discussion
In the present study, we tested an approach to deliver BDNF in a
conditional targeted fashion in an AD mouse model. We used a
transgenic mouse model recently generated and characterized by
our team (Giralt et al., 2010, 2011) to overexpress BDNF under
the GFAP promoter. Here we show how this method restores
the production and delivery of the neurotrophin in the dis-
eased neural tissue when the pathology starts because of the
accompanying astrogliosis. We first observed that endogenous
BDNF from astrocytes regulates neurite formation and spine
density in neurons in vitro. We then used a pGFAP:BDNF
transgene to rescue the BDNF loss in 5xFAD mice and observed a
significant improvement of learning and memory deficits in the hy-
brid transgenic mice. These improvements were associated with a
restoration of dendritic spines density and morphology and a recov-
ery of clusters of presynaptic and postsynaptic markers, synaptophy-
sin and PSD-95. We also observed a stronger LTP in CA1 in vivo in
behaving 5xF:pGB mice, which could be related with the other
changes.
We first demonstrated that BDNF produced by astrocytes can
play a relevant role in dendrite maturation. Although the present
results do not demonstrate a clear in vivo proof that BDNF is
produced and released in physiological conditions, they are in
line with the idea that astrocytes may play a role in synapse for-
mation and plasticity (Ronzano, 2017) and could play such a role
by regulating the BDNF availability to neurons (Vignoli et al.,
2016). They also reinforce the idea of astrocytes as potent regula-
tors of neurotrophin availability to neurons. After showing that
astrocytes are a potential source of BDNF with morphological
effects on neurons delivery, we generated the double-mutant
mice 5xF:pGB. We demonstrated that BDNF levels and the acti-
vation of TrkB and its downstream pathways (PLC and ERK1/2)
were fully recovered in these double-mutant 5xF:pGB mice,
which are the most important regulating synaptic plasticity path-
ways upon TrkB activation (Yoshii and Constantine-Paton,
2010). Indeed, PLC downstream signaling is essential for hip-
pocampal associative learning and CA3-CA1 LTP (Minichiello et
al., 2002; Gruart et al., 2007).
By comparing these double-mutant mice with 5xFAD mice,
we observed that the cognitive alterations related to hippocampal
dysfunction were rescued. Regarding the neuropathology, genet-
ically recovered BDNF levels did not change astrogliosis in
5xFAD mice. Normalization of BDNF levels increased the num-
ber of plaques but reduced their size. These findings contrast with
the belief that reduced plaque number associates with an amelio-
ration of the 5xFAD mice phenotype (Murphy and LeVine,
2010). However, the role of plaques is complex, and previous
reports have correlated a hyperaggregation of A with an im-
provement in AD transgenic mice phenotype due to a lower pres-
ence of soluble A, which is the most toxic form of the molecule
(Castellani et al., 2009; Cohen et al., 2009; Lublin and Gandy,
2010). We also checked for neurogenesis in the dentate gyrus,
which has been described to be altered (Moon et al., 2014), as a
possible neural correlate of the observed improvements. How-
ever, the number of Ki67-positive cells in the dentate gyrus were
equally reduced in 5xFAD and 5xF:pGB compared with WT
mice. These results revealed that behavioral improvements in
5xF:pGB mice did not result from plaque number reduction or
neurogenesis improvement. We therefore hypothesized that the
rescued phenotype in 5xF:pGB mice could be rather due to
changes in structural and functional synaptic properties. In
5xFAD mice, as well as in AD patients, there is a prominent
dendritic spine pathology and loss of synaptic markers, such as
synaptophysin and PSD-95 (Hongpaisan et al., 2011; Crowe and
Ellis-Davies, 2014; Yuki et al., 2014; Dorostkar et al., 2015; Yang
et al., 2015). We found several synaptic changes associated with
the cognitive improvements in 5xF:pGB mice. We hypothesize
that BDNF delivered from transgenic astrocytes may have in-
duced these changes by reactivating the neuronal TrkB-PLC/
ERK1/2 pathway. The PLC pathway is important for correct
PSD-95 location, whereas BDNF-TrkB-ERK is important for
PSD-95 expression (Robinet and Pellerin, 2011; Parsons et al.,
2014; Yoshii and Constantine-Paton, 2014). BDNF signaling can
also regulate synaptophysin levels (Tartaglia et al., 2001; Zhang et
al., 2017) and its function/location (Bamji et al., 2006). BDNF
could also be directly responsible for the rescue of dendritic
spine density and morphology as described previously (Kell-
ner et al., 2014). However, although here we show that BDNF
from astrocytes activates TrkB in neurons, we cannot rule out
a collateral effect of BDNF on neighboring astrocytes or even
microglia as previously described in the literature (Mizoguchi
et al., 2011; Sasi et al., 2017), producing a more widespread
effect than the one specifically evaluated in the present work.
Overall, our results strongly indicate that 5xF:pGB mice im-
provements could be due to a local and self-regulated delivery
of BDNF in the diseased tissue, likely rescuing the ERK1/2 and
PLC pathways in neurons, which in turn improved dendritic
spine pathology.
A significant body of evidence indicates that enhancement of
the BDNF delivery or function via activation of its high-affinity
receptor TrkB could be a promising therapeutic approach in AD
(Allen and Dawbarn, 2006; Devi and Ohno, 2012, 2015; Zhang et
al., 2014; Kaminari et al., 2017). Based on our results, we propose
that the use of engineered astrocytes could be an interesting
means to achieve this objective. Astrocytes are currently consid-
ered as very promising potential targets for AD treatment, in-
cluding through genetic manipulation to regulate neurotrophin
production (Bronzuoli et al., 2017; Gorshkov et al., 2018). In-
deed, astrocytes are uniquely positioned to promote the regener-
ation of damaged nerve cells or protect existing cells from
degeneration and dysfunction in the CNS (Anderson et al., 2016;
Blanco-Suárez et al., 2017). At least three main strategies have
been proposed: astrocyte transplantation or pharmacological
correction of their dysfunction or by its genetic manipulation
(Gorshkov et al., 2018). We propose that targeting astrocytes to
produce and deliver BDNF could be a potential therapeutic tool
for the treatment of AD. Much previous and present evidence
supports this idea. First, astrocytes have been recently shown to
be crucial for hippocampal-related cognitive function and syn-
4
(Figure legend continued.) Scale bar, 10 m. F, Quantification of the number of PSD-95/
phosphoTrkB Y816-positive puncta per field. One-way ANOVA: F(3,26) 	 5.303, p  0.01. G,
Electronic microscopy imaging of excitatory synapses in the stratum radiatum of the CA1 in
8-month-old WT, pGFAP-BDNF, 5xFAD, and 5xF:pGB mice. Asterisks indicate the presynaptic
component. Black arrows indicate the postsynaptic component. Scale bar, 0.3 m. H, Quanti-
fication of the PSD area. One-way ANOVA: F(3,253) 	 17.16, p  0.001. I, Quantification of the
number of presynaptic vesicles per synapse. One-way ANOVA: F(3,201) 	 9.18, p  0.001.
One-way ANOVA with Tukey’s test as a post hoc was used. Data are mean  SEM. B, D, F, H, I,
*p  0.05; ***p  0.001; compared with WT mice. $$p  0.01; $$$p  0.001; compared with
5xFAD mice. B, D, F, Two pictures per slice and 3 slices per mouse were taken. B, D, n 	
5/genotype. F, n 	 7–9/genotype. H, I, 51  3 excitatory synapses from 3 different mice/
genotype were evaluated.
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aptic plasticity (Adamsky et al., 2018).
Second, facilitating BDNF expression
from astrocytes has previously been
shown to be useful in another neurode-
generative disease, Huntington’s disease
(Giralt et al., 2011; Corbett et al., 2013;
Reick et al., 2016). Furthermore, astro-
cytes per se not only produce, but also
buffer, BDNF in case of necessity (Stary et
al., 2015) or recycle it for LTP mainte-
nance and memory retention (Vignoli et
al., 2016), thus making them perfect can-
didates to deliver the neurotrophin in a
controlled fashion. Additionally, in the
field of cell therapy, astrocytes would be
good therapeutic tools because they sur-
vive for a long time when grafted (Giralt et
al., 2010), and they are specifically reac-
tive where A is accumulated and where
neuritic dystrophy is localized (Song et
al., 2015). Furthermore, astrocytes are
easily manipulated, do not proliferate
aberrantly as for example engineered
cell lines (Hoffman et al., 1993), and
they do not suffer of teratogenic poten-
tial, in contrast to stem cells (Martínez-
Serrano and Björklund, 1996; Pineda et
al., 2007; Rubio et al., 1999). Neural cells
may be another candidate source for the
overexpression of BDNF. However, as an
excessive amount of this neurotrophin is
deleterious (Kells et al., 2008), its release
must be controlled (Martínez-Serrano
and Björklund, 1996; Rubio et al., 1999).
Transgenic astrocytes would overcome all
these drawbacks. A promising therapeutic
strategy could be the use of astrocytes
from induced pluripotent stem cells (Gor-
shkov et al., 2018). Once astrocytes have
been obtained and characterized and ge-
netically modified to express BDNF under
Figure 7. In vivo hippocampal synaptic plasticity in WT, pGFAP-BDNF, 5xFAD, and 5xF:pGB mice. A, Animals were chronically
implanted with bipolar stimulating electrodes in CA3 Schaffer (Sch.) collaterals and with a recording electrode in the ipsilateral CA1
area. Two extra wires were attached to the bone as ground. DG, Dentate gyrus. Right, Representative example of fEPSP (averaged
5 times) evoked at the CA3-CA1 synapse in a WT animal. B, Diagram illustrating the location of stimulating and recording elec-
trodes in the intrinsic hippocampal circuit. C, Representative micrographs illustrating the final location of stimulating and record-
ing electrodes. D, L, M, and V, dorsal, lateral, medial, and ventral, respectively. Calibration bar: 0.2 mm. D, Input/output curves of
fEPSPs evoked at the CA3-CA1 synapse by single pulses of increasing intensities (0.02– 0.4 in mA) in WT (n 	 13), pGFAP-BDNF
(n 	 15), 5xFAD (n 	 11), and 5xF:pGB (n 	 13) mice. Data are mean  SEM. No significant differences (F(3,912) 	 0.718; p 	
0.546) were observed between groups. E, No significant (F(15,240) 	 0.464; p 	 0.956) differences in paired-pulse facilitation
between the four experimental groups were observed (wt 	 15; pGFAP-BDNF 	 19; 5xFAD 	 13; 5xF:pGB 	 14). Data are
mean  SEM slopes of the second fEPSP expressed as the percentage of the first for six (10, 20, 40, 100, 200, and 500)
4
interpulse intervals. F, Graphs represent the time course of LTP
evoked in the CA3-CA1 synapse following an HFS session pre-
sented to mice included in the four experimental groups (wt,
n 	 16; pGFAP-BDNF, n 	 19; 5xFAD, n 	 13; 5xF:pGB, n 	
14). The HFS was presented after 15 min of baseline record-
ings, at the time marked by the dashed line. LTP evolution was
followed for 3 d. Top, Representative examples of fEPSPs col-
lected at the times indicated in the bottom graphs from a rep-
resentative animal of each group. fEPSP slopes are given as a
percentage of fEPSP values collected during baseline record-
ings (100%). Although the four groups presented significant
(F(114,1976) 	 1.863; p  0.001) increases (ANOVA, two-
tailed) in fEPSP slopes following HFS compared with baseline
recordings, the 5xF:pGB group did present a larger LTP than
that presented by the other three groups: *5xF:pGB versus WT;
5xF:pGB versus pGFAP-BDNF; &5xF:pGB versus 5xFAD; p 
0.045. Top left, inset, The evolution of paired-pulse facilitation
(determined at 40 ms of interpulse interval) for fEPSPs re-
corded during baseline and following the HFS session is illus-
trated for the four experimental groups. Dotted/dashed line
indicates the 5xFAD group.
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the GFAP promoter, they could be transplanted to promote the
survival and appropriate functioning of existing neurons, such as
synaptic plasticity processes.
Although 5xFAD mice presented noticeable losses in the ex-
pression of PSD-95 and synaptophysin, they did not present any
significant alteration in input/output curves, paired-pulse facili-
tation, or in LTP evoked in vivo. In this regard, it has been already
reported that LTP can be preserved longer than other behavioral
functions in aging mice (López-Ramos et al., 2012) and that mo-
tor exercise can help to recover some behavioral and associative
learning abilities, but not synaptic changes and LTP in 3xTg-AD
mice (García-Mesa et al., 2011). In addition, age seems to be a
critical factor; for example, in 3-month-old mice, it is almost
impossible to distinguish differences in learning abilities and LTP
strength and duration between WT versus APP, PS1, and APP-
PS1 mice (Gruart et al., 2008). For the present experiments, we
can assume that baseline measures of transmission (input/output
curves and paired-pulse facilitation) and LTP were sustained in
8-month-old 5xFAD mice by an increase in neurotransmitter
release (Fig. 7F), as reported by some of us in TgNTRK3 trans-
genic mice (Sahún et al., 2007). Indeed, the latter study is an
excellent example of dissociation between CA3-CA1 synaptic
plasticity and associative learning capabilities in genetically ma-
nipulated mice.
The present results have some limitations. First, although
the 5xFAD mouse model has been shown to recapitulate sev-
eral hallmarks of AD pathology, they do not show tauopathy
or formation of intraneuronal neurofibrillary tangles. From a
therapeutic point of view, the interpretation of our results
should be taken with caution, and studies evaluating our ap-
proach in models of tauopathy are needed. Second, we ob-
served recovered BDNF levels in 5xF:pGB mice with respect to
5xFAD mice at 8 months of age, but we cannot rule out the
possibility that earlier beneficial effects could have taken place
in our double-mutant mice. It is known that astrocytes syn-
thesize GFAP from the first days of age (Guo et al., 2013).
Thereby, putative early increases on BDNF levels in 5xF:pGB
mice could also counteract the deleterious effects of the five
transgenic mutations at very early stages.
In conclusion, our study supports the idea that the use of
engineered astrocytes to deliver BDNF under the control of the
GFAP promoter in AD has a strong potential. It may correspond
to the increase of a physiological function; and the delivery is
conditionally and locally administered, creating then a custom-
ized neurotrophin-based treatment.
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Canals JM, Alberch J (2009) Brain-derived neurotrophic factor modu-
lates the severity of cognitive alterations induced by mutant huntingtin:
involvement of phospholipaseCgamma activity and glutamate receptor
expression. Neuroscience 158:1234 –1250.
Giralt A, Friedman HC, Caneda-Ferrón B, Urbán N, Moreno E, Rubio N,
Blanco J, Peterson A, Canals JM, Alberch J (2010) BDNF regulation
under GFAP promoter provides engineered astrocytes as a new ap-
proach for long-term protection in Huntington’s disease. Gene Ther
17:1294 –1308.
Giralt A, Carretón O, Lao-Peregrin C, Martín ED, Alberch J (2011) Con-
ditional BDNF release under pathological conditions improves Hun-
tington’s disease pathology by delaying neuronal dysfunction. Mol
Neurodegener 6:71.
Giralt A, Brito V, Chevy Q, Simonnet C, Otsu Y, Cifuentes-Díaz C, de Pins B,
Coura R, Alberch J, Ginés S, Poncer JC, Girault JA (2017) Pyk2 modu-
lates hippocampal excitatory synapses and contributes to cognitive defi-
cits in a Huntington’s disease model. Nat Commun 8:15592.
Giralt A, de Pins B, Cifuentes-Díaz C, López-Molina L, Farah AT, Tible M,
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López-Ramos JC, Jurado-Parras MT, Sanfeliu C, Acuña-Castroviejo D,
Delgado-García JM (2012) Learning capabilities and CA1-prefrontal
synaptic plasticity in a mice model of accelerated senescence. Neurobiol
Aging 33:627–726.
Lublin AL, Gandy S (2010) Amyloid-beta oligomers: possible roles as key
neurotoxins in Alzheimer’s disease. Mt Sinai J Med 77:43– 49.
Lynch G, Rex CS, Chen LY, Gall CM (2008) The substrates of memory:
defects, treatments, and enhancement. Eur J Pharmacol 585:2–13.
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